Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension

被引:0
作者
Jordan C. Ray
Charles Burger
Patricia Mergo
Robert Safford
Joseph Blackshear
Christopher Austin
DeLisa Fairweather
Michael G. Heckman
Tonya Zeiger
Marcia Dubin
Brian Shapiro
机构
[1] Mayo Clinic,Department of Cardiovascular Disease
[2] Mayo Clinic,Department of Pulmonology
[3] Mayo Clinic,Department of Radiology
[4] Mayo Clinic,Division of Biomedical Statistics and Informatics
[5] Mayo Clinic,Clinical Studies Unit
来源
The International Journal of Cardiovascular Imaging | 2019年 / 35卷
关键词
Magnetic resonance imaging; Pulmonary hypertension; Pulmonary artery pulsatility;
D O I
暂无
中图分类号
学科分类号
摘要
Early detection of mild pulmonary arterial hypertension (PAH) based on clinical evaluation and echocardiography remains quite challenging. In addition to enhanced right ventricular (RV) assessment, cardiac magnetic resonance (CMR) imaging may accurately reflect deleterious remodeling and increased stiffness of the central pulmonary arteries based on pulsatility, or percent change of the PA during the cardiac cycle. The purpose of this study is to assess the utility of measuring PA pulsatility by CMR as a potential early maker in PAH. We hypothesize that pulsatility may help discriminate mild PAH from normal control subjects. Consecutive patients with PAH (n = 51) were prospectively enrolled to receive same day CMR and right heart catheterization (RHC). PA stiffness indices including pulsatility, distensibility, compliance, and capacitance were calculated. Comparisons were made between patients with varying severities of PAH and normal controls (n = 18). Of the 51 subjects, 20 had mild PAH, and 31 moderate-severe based on hemodynamic criteria. PA pulsatility demonstrated a progressive decline from normal controls (53%), mild PAH (22%), to moderate-severe PAH (17%; p < 0.001). There was no difference in RV size, function or mass between mild PAH and normal controls. PA pulsatility below 40% had an excellent ability to discriminate between mild PAH and normal controls with a sensitivity of 95% and specificity of 94%. CMR assessment of PA stiffness may noninvasively detect adverse pulmonary vascular remodeling and mild PAH, and thus be a valuable tool for early detection of PAH. Trial Registration: ClinicalTrials.gov Identifier: NCT01451255; https://clinicaltrials.gov/ct2/show/NCT01451255.
引用
收藏
页码:1881 / 1892
页数:11
相关论文
共 387 条
[21]  
Garcia-Alvarez A(1994)Quantification of hemodynamics in primary pulmonary-hypertension with magnetic-resonance-imaging Am J Respir Crit Care Med 150 1075-31
[22]  
Fernandez-Friera L(2013)Noninvasive estimation of PA pressure, flow, and resistance With CMR imaging derivation and prospective validation study from the ASPIRE registry Jacc-Cardiovasc Imag 6 1036-1401
[23]  
Nair A(2012)Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension Invest Radiol 47 571-481
[24]  
Mirelis JG(2007)Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging Radiology 243 70-2251
[25]  
Sawit ST(2011)Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance Eur Heart J 32 2438-1695
[26]  
Pinney S(1993)Detection and quantification of pulmonary-artery hypertension with Mr-imaging—results in 23 patients Am J Roentgenol 161 27-1897
[27]  
Fuster V(2010)Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure CHEST J 138 1395-649
[28]  
Rolf A(2007)Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study Eur Respir J 29 476-910
[29]  
Rixe J(2011)Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension Circ J 75 2244-1814
[30]  
Kim WK(2008)Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension Eur Heart J 29 1688-868